|
EVERYTHING
Trump Threatens to End 50 Years of Nurses' Health Study
What: CNN has the details on the Trump's administration threats to cut funding for a 50-year study involving 280,000 nurses that has led to significant medical advancements. Pulling the funding for the study is part of the administration's threats against Harvard University.
Key Line: "Data from the Nurses’ Health Study has vastly improved how all Americans live and eat while also impacting the health of people around the world, Willett said. 'From the efforts of these dedicated nurses we learned trans fats were terrible for health, and now those are basically gone from our food supply,' he said. 'We also found one of the earliest links between cigarette smoking and heart disease.'"
Source: CNN
Hysterectomies Aren't Always a Tragedy
What: Hysterectomies can be viewed as a tragic outcome, but author Andrea Becker writes that they are also a lifesaving *and* quality-of-life saving procedure for women dealing with issues like severe bleeding, endometriosis, or uterine prolapse. Many patients experience significant relief and satisfaction following the procedure.
Key Line: "Uteruses are a part of women’s bodies that affect them; they are not simply for pregnancy. They should be studied as the core component of the body that the doctors reluctant to remove them claim they are. There should be more ways to provide relief to people who have heavy periods and pain, whether it’s from fibroids, PCOS, or endometriosis, diseases that doctors have known about for over 90 years."
Source: Slate
PREGNANCY + POSTPARTUM
Low Blood Pressure in Pregnancy Not Tied to Small Babies
What: A study analyzed the birth weight of babies born to women who had high blood pressure earlier in pregnancy, which was then treated and led to low blood pressure in the third trimester. They found having low blood pressure didn't impact the likelihood of having a small-for-gestational-age baby.
Key Line: "Pharmacologic treatment of mild chronic hypertension infrequently results in low BP and does not appear to be associated with delivery of a neonate with [small-for-gestational-age] birth weight less than the 5th percentile for birth weight."
Source: Obstetrics & Gynecology
MENOPAUSE
Hormone Therapy Supercharges Weight Loss Drugs After Menopause
What: Combining a GLP-1 drug, tirzepatide, with menopause hormone therapy helps postmenopausal women lose more weight than the GLP-1 drug alone, according to a study presented at the Endocrine Society's annual meeting. The combination of the treatments appears to make both more effective.
Key Line: "'These data are the first to show the combined use of tirzepatide and menopause hormone therapy significantly increases treatment effectiveness in postmenopausal women,' said Regina Castaneda, M.D., research fellow for the Division of Endocrinology at the Mayo Clinic in Jacksonville, Fla. 'Previous studies of the medication semaglutide found similar results. Achieving these outcomes with a second obesity medication may indicate a broader efficacy trend for pairing these two classes of medications.'"
Source: Science Daily
ONCOLOGY
Weight-Loss Drug Shrinks Breast Cancer Tumors in Mouse Study
What: A mouse study found the GLP-1 weight loss drug tirzepatide, sold as Mounjaro for diabetes and Zepbound for obesity, decreased the growth of obesity-linked breast cancer tumors. This could potentially reduce the breast cancer risks associated with obesity.
Key Line: "'Obesity is a significant risk factor for breast cancer, and while it is very preliminary data, our studies in mice suggest that these new anti-obesity drugs may be a way to reduce obesity-associated breast cancer risk or improve outcomes,' said study author Amanda Kucinskas, B.S., a Ph.D. candidate in the labs of Drs. Erin Giles and Kanakadurga Singer at the University of Michigan in Ann Arbor, Mich."
Source: Science Daily
|